Antioxidant status in acute stroke patients and patients at stroke risk - PubMed (original) (raw)
Comparative Study
doi: 10.1159/000077662. Epub 2004 Apr 1.
Affiliations
- PMID: 15073440
- DOI: 10.1159/000077662
Free article
Comparative Study
Antioxidant status in acute stroke patients and patients at stroke risk
C Zimmermann et al. Eur Neurol. 2004.
Free article
Abstract
Background and purpose: Antioxidant enzymes like copper/zinc superoxide dismutase (SOD), catalase and gluthatione peroxidase (GSHPx) are part of intracellular protection mechanisms to overcome oxidative stress and are known to be activated in vascular diseases and acute stroke. We investigated the differences of antioxidant capacity in acute stroke and stroke risk patients to elucidate whether the differences are a result of chronic low availability in arteriosclerosis and stroke risk or due to changes during acute infarction.
Methods: Antioxidant enzymes were examined in 11 patients within the first hours and days after acute ischemic stroke and compared to risk- and age-matched patients with a history of stroke in the past 12 months (n = 17). Antioxidant profile was determined by measurement of glutathione (GSH), malondialdehyde (MDA), SOD, GSHPx and minerals known to be involved in antioxidant enzyme activation like selenium, iron, copper and zinc.
Results: In comparison to stroke risk patients, patients with acute ischemic stroke had significant changes of the GSH system during the first hours and days after the event: GSH was significantly elevated in the first hours (p < 0.01) and GSHPx was elevated 1 day after the acute stroke (p < 0.05). Selenium, a cofactor of GSHPx, was decreased (p < 0.01). GSHPx levels were negatively correlated with National Institutes of Health Stroke Scale (NIHSS) scores on admission (r = -0.84, p < 0.001) and NIHSS scores after 7 days (r = -0.63, p < 0.05). MDA levels showed a trend for elevation in the first 6 h after the acute stroke (p = 0.07). No significant differences of SOD, iron, copper nor zinc levels could be identified.
Conclusions: Differences of antioxidant capacity were found for the GSH system with elevation of GSH and GSHPx after acute stroke, but not for other markers. The findings support the hypothesis that changes of antioxidant capacity are part of acute adaptive mechanisms during acute stroke.
Copyright 2004 S. Karger AG, Basel
Similar articles
- Tumour necrosis factor alpha, lipid peroxidation and NO* are increased and associated with decreased free-radical scavenging enzymes in patients with Weill-Marchesani syndrome.
Evereklioglu C, Turkoz Y, Calis M, Duygulu F, Karabulut AB. Evereklioglu C, et al. Mediators Inflamm. 2004 Jun;13(3):165-70. doi: 10.1080/09511920410001713547. Mediators Inflamm. 2004. PMID: 15223607 Free PMC article. - Oxidative stress: correlation with Behçet's disease duration, activity and severity.
Harzallah O, Kerkeni A, Baati T, Mahjoub S. Harzallah O, et al. Eur J Intern Med. 2008 Nov;19(7):541-7. doi: 10.1016/j.ejim.2008.08.001. Epub 2008 Sep 11. Eur J Intern Med. 2008. PMID: 19013385 - Evaluation of oxidative stress in patients with acute ischemic stroke.
Cojocaru IM, Cojocaru M, Sapira V, Ionescu A. Cojocaru IM, et al. Rom J Intern Med. 2013 Apr-Jun;51(2):97-106. Rom J Intern Med. 2013. PMID: 24294813 Review. - Targeting antioxidant enzyme expression as a therapeutic strategy for ischemic stroke.
Davis SM, Pennypacker KR. Davis SM, et al. Neurochem Int. 2017 Jul;107:23-32. doi: 10.1016/j.neuint.2016.12.007. Epub 2016 Dec 30. Neurochem Int. 2017. PMID: 28043837 Free PMC article. Review.
Cited by
- Neuroprotective effect of humic Acid on focal cerebral ischemia injury: an experimental study in rats.
Ozkan A, Sen HM, Sehitoglu I, Alacam H, Guven M, Aras AB, Akman T, Silan C, Cosar M, Karaman HI. Ozkan A, et al. Inflammation. 2015 Feb;38(1):32-9. doi: 10.1007/s10753-014-0005-0. Inflammation. 2015. PMID: 25173888 - Pilot results of in vivo brain glutathione measurements in stroke patients.
An L, Dani KA, Shen J, Warach S; Natural History of Stroke Investigators. An L, et al. J Cereb Blood Flow Metab. 2012 Dec;32(12):2118-21. doi: 10.1038/jcbfm.2012.127. Epub 2012 Sep 26. J Cereb Blood Flow Metab. 2012. PMID: 23010948 Free PMC article. Clinical Trial. - Selenium, Copper, Zinc Concentrations and Cu/Zn, Cu/Se Molar Ratios in the Serum of Patients with Acute Ischemic Stroke in Northeastern Poland-A New Insight into Stroke Pathophysiology.
Mirończuk A, Kapica-Topczewska K, Socha K, Soroczyńska J, Jamiołkowski J, Kułakowska A, Kochanowicz J. Mirończuk A, et al. Nutrients. 2021 Jun 22;13(7):2139. doi: 10.3390/nu13072139. Nutrients. 2021. PMID: 34206577 Free PMC article. - Matrine exerts its neuroprotective effects by modulating multiple neuronal pathways.
Chhabra S, Mehan S. Chhabra S, et al. Metab Brain Dis. 2023 Jun;38(5):1471-1499. doi: 10.1007/s11011-023-01214-6. Epub 2023 Apr 27. Metab Brain Dis. 2023. PMID: 37103719 Review. - Neuroprotective Effect of Matrine in Mouse Model of Vincristine-Induced Neuropathic Pain.
Gong SS, Li YX, Zhang MT, Du J, Ma PS, Yao WX, Zhou R, Niu Y, Sun T, Yu JQ. Gong SS, et al. Neurochem Res. 2016 Nov;41(11):3147-3159. doi: 10.1007/s11064-016-2040-8. Epub 2016 Aug 25. Neurochem Res. 2016. PMID: 27561290
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous